3-Jan-2025
No headlines found.
Phreesia Announces Third Quarter Fiscal 2025 Results
Business Wire (Mon, 9-Dec 4:05 PM ET)
Phreesia Named to The Software Report's "Top 100 Software Companies" for the Third Consecutive Year
Business Wire (Fri, 22-Nov 6:48 AM ET)
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results
Business Wire (Fri, 1-Nov 6:48 AM ET)
Business Wire (Mon, 28-Oct 6:48 AM ET)
Business Wire (Tue, 8-Oct 6:48 AM ET)
Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.
Phreesia trades on the NYSE stock market under the symbol PHR.
As of January 3, 2025, PHR stock price climbed to $26.20 with 234,825 million shares trading.
PHR has a beta of 1.48, meaning it tends to be more sensitive to market movements. PHR has a correlation of 0.13 to the broad based SPY ETF.
PHR has a market cap of $1.50 billion. This is considered a Small Cap stock.
Last quarter Phreesia reported $107 million in Revenue and -$.25 earnings per share. This beat revenue expectation by $800,000 and exceeded earnings estimates by $.04.
In the last 3 years, PHR traded as high as $43.47 and as low as $12.05.
The top ETF exchange traded funds that PHR belongs to (by Net Assets): IWM, VTI, VXF, VB, IWO.
PHR has underperformed the market in the last year with a return of +18.6%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PHR shares. However, PHR has outperformed the market in the last 3 month and 2 week periods, returning +18.7% and +4.1%, while SPY returned +4.6% and +0.1%, respectively. This indicates PHR has been having a stronger performance recently.
PHR support price is $24.31 and resistance is $26.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHR shares will trade within this expected range on the day.